EUVIMEDEUVIMED entdecken
Open Access

Peripheral immune biomarkers associated with response to adoptive cell therapy with tumor infiltrating lymphocytes

Cecilie Oelvang Madsen iD, Marta Velasco Santiago, Evelina Martinenaite, Troels Holz Borch, Marco Donia, Inge Marie Svane, Morten Hansen

Clinical and Experimental Immunology · 21.01.2025 · 219 (1)

DOI: 10.1093/cei/uxaf010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 18.02.2025. Verfasst von Cecilie Oelvang Madsen und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Immunotherapy, Adoptive, Melanoma, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Danish Cancer Society, The Danish Council for Independent Research, Capital Region of Denmark Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adoptive cell therapy (ACT) with ex-vivo expanded tumor-infiltrating lymphocytes (TILs, TIL-ACT) has shown clinical efficacy in a significant proportion of patients with metastatic melanoma. To further target TIL-ACT toward responsive patients, identifying predictive biomarkers and understanding broader immune dynamics remain critical. This study investigated the peripheral blood immune landscape in 47 patients with metastatic melanoma undergoing TIL-ACT, assessing antitumor reactivity and peripheral immune cell profiles before and after treatment. Responders displayed increased frequency of circulating tumor-reactive cells post-treatment, and higher baseline levels of activated CD57-expressing T cells, serving as potential biomarkers of response. In contrast, persistent high serum levels of interleukin (IL)-6 and IL-8, higher frequencies of CD38-expressing T cells, and regulatory T cells (Tregs) post-treatment, correlated with unfavorable outcomes. These findings contribute to understanding the peripheral immune landscape associated with response to TIL-ACT, offering valuable insights into predictive biomarkers and mechanisms to improve patient selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingImmunotherapy, AdoptiveMelanomaBiomarkers, TumorT-Lymphocytes, RegulatoryHumansMaleFemaleMiddle AgedAgedAdultInterleukin-6Interleukin-8CD57 AntigensADP-ribosyl Cyclase 1

Stichwörter der Autor:innen

adoptive cell therapybiomarkersimmune monitoringmetastatic melanomatumor infiltrating lymphocytes

Substanzen

Biomarkers, TumorInterleukin-6Interleukin-8CD57 AntigensADP-ribosyl Cyclase 1

Autor:innen und Institutionen

  • National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.

ORCID-Profile: Cecilie Oelvang Madsen

Förderung

  • Danish Cancer Society
  • The Danish Council for Independent Research
  • Capital Region of Denmark Research Foundation

Zitieren

APA

Madsen, C. O., Velasco Santiago, M., Martinenaite, E., Holz Borch, T., Donia, M., Svane, I. M., & Hansen, M. (2025). Peripheral immune biomarkers associated with response to adoptive cell therapy with tumor infiltrating lymphocytes. Clinical and Experimental Immunology, 219(1). https://doi.org/10.1093/cei/uxaf010

Vancouver

Madsen CO, Velasco Santiago M, Martinenaite E, Holz Borch T, Donia M, Svane IM, et al. Peripheral immune biomarkers associated with response to adoptive cell therapy with tumor infiltrating lymphocytes. Clinical and Experimental Immunology. 2025;219(1). doi:10.1093/cei/uxaf010

BibTeX
@article{Madsen2025,
  author = {Madsen, Cecilie Oelvang and Velasco Santiago, Marta and Martinenaite, Evelina and Holz Borch, Troels and Donia, Marco and Svane, Inge Marie and Hansen, Morten},
  title = {Peripheral immune biomarkers associated with response to adoptive cell therapy with tumor infiltrating lymphocytes},
  journal = {Clinical and Experimental Immunology},
  year = {2025},
  volume = {219},
  number = {1},
  doi = {10.1093/cei/uxaf010}
}
Kostenlos starten →